Fukunaga K - Search Results

1

The Role of CaMKII and ERK Signaling in Addiction.

Jia W, Kawahata I, Cheng A, Fukunaga K. Jia W, et al. Among authors: fukunaga k. Int J Mol Sci. 2021 Mar 20;22(6):3189. doi: 10.3390/ijms22063189. Int J Mol Sci. 2021. PMID: 33804804 Free PMC article. Review.

2

[Role of heart-type fatty acid binding protein in the brain function].

Motohashi K, Yamamoto Y, Shioda N, Kondo H, Owada Y, Fukunaga K. Motohashi K, et al. Among authors: fukunaga k. Yakugaku Zasshi. 2009 Feb;129(2):191-5. doi: 10.1248/yakushi.129.191. Yakugaku Zasshi. 2009. PMID: 19182446 Free article. Review. Japanese.

3

DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities.

Lu YM, Shioda N, Han F, Kamata A, Shirasaki Y, Qin ZH, Fukunaga K. Lu YM, et al. Among authors: fukunaga k. Cardiovasc Ther. 2009 Spring;27(1):17-27. doi: 10.1111/j.1755-5922.2008.00068.x. Cardiovasc Ther. 2009. PMID: 19207476 Free article.

4

Role of Akt and ERK signaling in the neurogenesis following brain ischemia.

Shioda N, Han F, Fukunaga K. Shioda N, et al. Among authors: fukunaga k. Int Rev Neurobiol. 2009;85:375-87. doi: 10.1016/S0074-7742(09)85026-5. Int Rev Neurobiol. 2009. PMID: 19607982 Review.

5

Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation.

Yamamoto Y, Shioda N, Han F, Moriguchi S, Nakajima A, Yokosuka A, Mimaki Y, Sashida Y, Yamakuni T, Ohizumi Y, Fukunaga K. Yamamoto Y, et al. Among authors: fukunaga k. Brain Res. 2009 Oct 27;1295:218-29. doi: 10.1016/j.brainres.2009.07.081. Epub 2009 Jul 30. Brain Res. 2009. PMID: 19646972

6

Heart-type fatty acid binding protein regulates dopamine D2 receptor function in mouse brain.

Shioda N, Yamamoto Y, Watanabe M, Binas B, Owada Y, Fukunaga K. Shioda N, et al. Among authors: fukunaga k. J Neurosci. 2010 Feb 24;30(8):3146-55. doi: 10.1523/JNEUROSCI.4140-09.2010. J Neurosci. 2010. PMID: 20181611 Free PMC article.

7

Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: proteins interacting with the third cytoplasmic loop of dopamine D2 and D3 receptors.

Shioda N, Takeuchi Y, Fukunaga K. Shioda N, et al. Among authors: fukunaga k. J Pharmacol Sci. 2010;114(1):25-31. doi: 10.1254/jphs.10r02fm. Epub 2010 Aug 12. J Pharmacol Sci. 2010. PMID: 20716856 Free article. Review.

8

Sigma-1 receptor stimulation by dehydroepiandrosterone ameliorates cognitive impairment through activation of CaM kinase II, protein kinase C and extracellular signal-regulated kinase in olfactory bulbectomized mice.

Moriguchi S, Yamamoto Y, Ikuno T, Fukunaga K. Moriguchi S, et al. Among authors: fukunaga k. J Neurochem. 2011 Jun;117(5):879-91. doi: 10.1111/j.1471-4159.2011.07256.x. Epub 2011 Apr 19. J Neurochem. 2011. PMID: 21434925 Free article.

9

[Dopamine D2 receptor as a novel target molecule for heart-type fatty acid binding protein].

Shioda N, Yamamoto Y, Owada Y, Fukunaga K. Shioda N, et al. Among authors: fukunaga k. Nihon Shinkei Seishin Yakurigaku Zasshi. 2011 Jun;31(3):125-30. Nihon Shinkei Seishin Yakurigaku Zasshi. 2011. PMID: 21800703 Japanese.

10

Novel dopamine D2 receptor signaling through proteins interacting with the third cytoplasmic loop.

Fukunaga K, Shioda N. Fukunaga K, et al. Mol Neurobiol. 2012 Feb;45(1):144-52. doi: 10.1007/s12035-011-8227-8. Epub 2011 Dec 20. Mol Neurobiol. 2012. PMID: 22183739 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,418 results

Search Page

Filters